Nifedipine Tablet, Extended Release
Product Images NDC 68071-2619

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 68071-2619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2619 3)

Nifedipine 30 mg extended-release tablets label from NuCare Pharmaceuticals, Inc., NDC 68071-2619-3. The label states each tablet is a round yellow tablet debossed with "30" on one side. Manufactured by Novast Laboratories, Ltd. in China, with packaging by NuCare Pharmaceuticals, Inc., Orange, CA. The package contains 30 tablets and includes warnings and storage instructions.*

FDA Label Image

01 (Image 01)

Chemical structure of nifedipine showing its molecular components including nitro group, ester, and methyl groups arranged on a dihydropyridine ring and a benzene ring.*

FDA Label Image

02 (Image 02)

A table comparing the percentage of patients experiencing adverse effects between nifedipine extended-release tablets and placebo. It lists headache, fatigue, dizziness, constipation, and nausea with their respective occurrence percentages for each group.*

FDA Label Image

03 (Image 03)

A data table presenting adverse effects reported in subjects taking Nifedipine extended release capsules compared to a placebo group. It lists specific adverse effects such as dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion, with the percentage of subjects experiencing each event in both groups.*

FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.